Iron Supplementation and Neurodevelopmental Outcome in ELGANs

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions

Iron-deficiency

Interventions

DRUG

Iron Sulfate

Early, high dose, iron supplementation

Trial Locations (1)

Prentice Women's Hospital, Chicago

All Listed Sponsors

lead

Ann & Robert H Lurie Children's Hospital of Chicago

OTHER

NCT04691843 - Iron Supplementation and Neurodevelopmental Outcome in ELGANs | Biotech Hunter | Biotech Hunter